{"id":3212,"date":"2026-06-10T06:00:52","date_gmt":"2026-06-10T11:00:52","guid":{"rendered":"https:\/\/www.worldcare.com\/?p=3212"},"modified":"2026-06-10T06:49:13","modified_gmt":"2026-06-10T11:49:13","slug":"sto-otkrivanje-raka-gusterace-govori-osiguravateljima-o-misljenjima-strucnjaka-u-medicini","status":"publish","type":"post","link":"https:\/\/www.worldcare.com\/hr\/what-a-pancreatic-cancer-breakthrough-tells-insurers-about-expert-medical-opinions\/","title":{"rendered":"\u0160to otkri\u0107e u raku gu\u0161tera\u010de govori osiguravateljima o mi\u0161ljenjima stru\u010dnjaka"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"3212\" class=\"elementor elementor-3212\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5b2feeaa e-flex e-con-boxed e-con e-parent\" data-id=\"5b2feeaa\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-baac94d elementor-widget elementor-widget-text-editor\" data-id=\"baac94d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Lijek koji znanstvenici nazivaju &quot;ekvivalentom prelaska milje za \u010detiri minute protiv raka&quot; bli\u017ei se regulatornom odobrenju. Daraxonrasib cilja protein koji poti\u010de gotovo sve tumore gu\u0161tera\u010de - kao i mnoge vrste raka plu\u0107a i debelog crijeva - i u <a href=\"https:\/\/ir.revmed.com\/news-releases\/news-release-details\/daraxonrasib-demonstrates-unprecedented-overall-survival-benefit\/\" target=\"_blank\" rel=\"noreferrer noopener\">klju\u010dno ispitivanje u kasnoj fazi,<\/a> gotovo je udvostru\u010dio medijan pre\u017eivljavanja kod pacijenata s metastatskim rakom gu\u0161tera\u010de sa 6,7 mjeseci na 13,2 mjeseca.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Inovacija je zapanjuju\u0107a zbog svog potencijala da reinventira pristupe lije\u010denju i uspore\u0111uje se s revolucionarnim utjecajem imunoterapije prije 15 godina.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Tako\u0111er je zna\u010dajno po tome gdje se nalazi u \u0161irem obrascu: dok se otkri\u0107a poput Daraxonrasiba doga\u0111aju sporadi\u010dno, medicinsko znanje op\u0107enito napreduje tempom koji nijedan pojedina\u010dni klini\u010dar, zdravstveni sustav ili zemlja ne mo\u017ee u potpunosti samostalno apsorbirati - a s globalnim, multidisciplinarnim medicinskim drugim mi\u0161ljenjima dostupnijim nego ikad putem zdravstvenih planova, osiguranja za kriti\u010dne bolesti, pa \u010dak i usluga poput kreditnih kartica ili pogodnosti hotelskog smje\u0161taja, to ne moraju \u010diniti. \u00a0<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:heading --><\/p>\n<h2 class=\"wp-block-heading\"><strong>Tempo inovacija u onkologiji poziv je na bu\u0111enje za zdravstvene planove<\/strong><\/h2>\n<p><!-- \/wp:heading --><!-- wp:paragraph --><\/p>\n<p>Napredak lijekova i medicinske tehnologije pru\u017ea opipljive pokazatelje zapanjuju\u0107ih inovacija u medicini. Razmotrite \u0161to se dogodilo samo u posljednjih nekoliko mjeseci:<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:list --><\/p>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\"><!-- wp:list-item --><\/ul>\n<\/li>\n<\/ul>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\">\n<li>Od svibnja 2026. godine, <a href=\"https:\/\/www.ema.europa.eu\/en\/news\/meeting-highlights-committee-medicinal-products-human-use-chmp-18-21-may-2026\" target=\"_blank\" rel=\"noopener\">Europska agencija za lijekove<\/a>\u00a0izdala je 36 pozitivnih mi\u0161ljenja o novim lijekovima i 59 dodatnih mi\u0161ljenja kojima se pro\u0161iruju odobrene upotrebe postoje\u0107ih tretmana.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><!-- \/wp:list-item --><!-- wp:list-item --><\/p>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.canada.ca\/en\/health-canada\/news\/2026\/03\/new-task-force-to-enhance-canadas-competitiveness-and-improve-access-to-innovative-medicines.html\" target=\"_blank\" rel=\"noreferrer noopener\">Zdravstvo Kanade <\/a>odobrila je 56 novih farmaceutskih lijekova, 23 nova biolo\u0161ka lijeka, 134 generi\u010dka farmaceutska lijeka i 12 biosimilara izme\u0111u travnja 2025. i velja\u010de 2026. Od njih, 43 sadr\u017ei ljekovite sastojke koji nikada prije nisu bili odobreni za prodaju u Kanadi.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><!-- \/wp:list-item --><!-- wp:list-item --><\/p>\n<ul class=\"wp-block-list\">\n<li style=\"list-style-type: none;\">\n<ul class=\"wp-block-list\">\n<li>Od 1. lipnja 2026. godine, <a href=\"https:\/\/www.fda.gov\/drugs\/novel-drug-approvals-fda\/novel-drug-approvals-2026\" target=\"_blank\" rel=\"noreferrer noopener\">Ameri\u010dka agencija za hranu i lijekove<\/a> odobrio je 20 potpuno novih lijekova, ne ra\u010dunaju\u0107i nove indikacije.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><!-- \/wp:list-item --><\/p>\n<p><!-- \/wp:list --><!-- wp:paragraph --><\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Tempo inovacija u onkologiji, posebno, nastavlja se ubrzavati. U posljednjem desetlje\u0107u, 115 novih tretmana raka odobreno je za 10 naj\u010de\u0161\u0107ih vrsta raka - u odnosu na 28 odobrenja u desetlje\u0107u prije, prema <a href=\"https:\/\/www.airfinity.com\/articles\/300-rise-in-approved-new-cancer-treatments-in-the-last-two-decades-with-us\" target=\"_blank\" rel=\"noreferrer noopener\">Analiza zra\u010dne konope<\/a> koji tako\u0111er primje\u0107uje zna\u010dajan dio kombiniranih tretmana koji se koriste u ciljanim terapijama.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:heading --><\/p>\n<h2 class=\"wp-block-heading\"><strong>Multidisciplinarna medicinska druga mi\u0161ljenja poma\u017eu osiguravateljima da premostiju jaz u znanju<\/strong><\/h2>\n<p><!-- \/wp:heading --><!-- wp:paragraph --><\/p>\n<p>Medicinsko znanje se sada procjenjuje na <a href=\"https:\/\/connection.asco.org\/do\/staying-current-todays-era-rapidly-evolving-medical-advances#:~:text=1,decade%20from%202010%20to%202020.%E2%80%9D\" target=\"_blank\" rel=\"noreferrer noopener\">udvostru\u010duje se svakih 73 dana<\/a>, prema Ameri\u010dkom dru\u0161tvu za klini\u010dku onkologiju. Nijedan lije\u010dnik ne mo\u017ee pratiti taj tempo. Kao \u0161to je kirurg i autor Atul Gawande rekao <a href=\"https:\/\/www.newyorker.com\/news\/news-desk\/cowboys-and-pit-crews\" target=\"_blank\" rel=\"noreferrer noopener\">sva\u0111ao se<\/a>, medicina je postala previ\u0161e slo\u017eena za model solo stru\u010dnjaka. Moderni standard zahtijeva multidisciplinarnu, timski utemeljenu specijalisti\u010dku skrb.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Ovdje <a href=\"http:\/\/www.worldcare.com\/hr\/\" target=\"_blank\" rel=\"noreferrer noopener\" data-type=\"link\" data-id=\"www.worldcare.com\">globalna medicinska druga mi\u0161ljenja <\/a>postaju kriti\u010dni. Kada pacijent u Poljskoj, Kanadi ili Saudijskoj Arabiji dobije ozbiljnu dijagnozu, njegov ishod ovisi o tome ima li njihov tim za njegu pristup specijalistima koji poznaju najnovije dokaze i mogu ih primijeniti na njihov specifi\u010dan slu\u010daj.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Proboj koji se danas bli\u017ei odobrenju FDA ili EMA mogao bi postati standard skrbi unutar godine dana. Za grupne zdravstvene planove, police osiguranja za kriti\u010dne bolesti i TPA-ove koji pru\u017eaju usluge \u010dlanovima diljem Sjeverne Amerike, Europe, Afrike i Zaljeva, me\u0111unarodna usluga stru\u010dnog medicinskog mi\u0161ljenja vi\u0161e nije dodatna ponuda - to je pobolj\u0161anje pogodnosti koje izravno utje\u010de na kvalitetu skrbi koju \u010dlanovi primaju i to\u010dnost zahtjeva koji slijede.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p>Nudenje pristupa multidisciplinarnim timskim drugim mi\u0161ljenjima o ozbiljnim i slo\u017eenim dijagnozama jedan je od najjasnijih oblika inovacija grupnih pogodnosti dostupnih osiguravateljima danas. Na tr\u017ei\u0161tu gdje se medicinsko znanje nakuplja br\u017ee nego \u0161to to bilo koji lije\u010dnik mo\u017ee pratiti, to je ujedno i jedan od najobranjivijih na\u010dina.<\/p>\n<p><!-- \/wp:paragraph --><!-- wp:paragraph --><\/p>\n<p><!-- \/wp:paragraph --><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>A drug that scientists are calling \u201ccancer&#8217;s equivalent of breaking the four-minute mile\u201d is nearing regulatory approval. Daraxonrasib targets a protein that drives nearly all pancreatic tumors \u2014 as well as many lung and colon cancers \u2014 and in a late-stage pivotal trial, it nearly doubled median survival in patients with metastatic pancreatic cancer from [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":3256,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[158,35,16],"tags":[],"class_list":["post-3212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-innovation","category-cancer","category-medical-second-opinion"],"_links":{"self":[{"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/posts\/3212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/comments?post=3212"}],"version-history":[{"count":0,"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/posts\/3212\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/media\/3256"}],"wp:attachment":[{"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/media?parent=3212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/categories?post=3212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.worldcare.com\/hr\/wp-json\/wp\/v2\/tags?post=3212"}],"curies":[{"name":"radni list","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}